exRNAdisease

Entry Detail

---



General Information

Database ID: exR0270334 RNA Name: hsa-miR-671-5p RNA Type: miRNA Chromosome: chr7 Starnd: + Coordinate: Start Site(bp): 151238449 End Site(bp): 151238471 External Links: hsa-miR-671-5p

Disease Information

Disease Name: Multiple Sclerosis Disease Category: Nervous System Diseases MeSH ID: D009103 Type: Diseases Category/Nervous System Diseases Alias: Sclerosis, Multiple//Sclerosis, Disseminated//Disseminated Sclerosis//MS (Multiple Sclerosis)//Multiple Sclerosis, Acute Fulminating

Expression Detail

GEO ID: GSE140106 Description: Serum exosome microRNAs predict multiple sclerosis disease activity after fingolimod treatment Experimental Design: Fingolimod treatment Case Disease Type: Multiple Sclerosis Case Disease SubType: NA Case Sample: Fingolimod treated Multiple Sclerosis Control Sample: Untreated Number of Case: 27 Number of Control: 27 Number of Samples: 54

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand RCOR1 chr14 102592649 102730561 + KIAA0232 chr4 6781375 6884170 + TAF8 chr6 42050513 42087461 + MAFG chr17 81918270 81927735 - DYRK1A chr21 37365573 37526358 + MED22 chr9 133338312 133348131 - KLC1 chr14 103561896 103714249 + CBX6 chr22 38861422 38872249 - SAMD4B chr19 39342396 39385710 + GTSE1 chr22 46296870 46330810 + SETD5 chr3 9397615 9479240 + CREG1 chr1 167529117 167553805 - IRS2 chr13 109752695 109786583 - SCAMP3 chr1 155255979 155262430 - CCDC6 chr10 59788747 59906556 - BAZ2A chr12 56595596 56636816 - WDR82 chr3 52254434 52288020 - TOMM6 chr6 41787662 41789898 + FAM219A chr9 34398184 34458570 - STAT3 chr17 42313324 42388568 - UHRF1BP1 chr6 34792015 34883138 + AL365205.1 chr6 41780349 41790141 + NACC1 chr19 13116862 13141147 + SMAD3 chr15 67063763 67195169 + WDTC1 chr1 27234632 27308636 + IL1R1 chr2 102064544 102179874 + PTPRU chr1 29236516 29326813 + GLYR1 chr16 4803203 4847288 - APLP2 chr11 130068147 130144811 + CHTF8 chr16 69118010 69132578 - miRNA targets: NA circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC067930.1 chr8 143579636 143580670 + AC145207.5 chr17 81878425 81881106 - AL022311.1 chr22 37876148 37895563 + AL137127.1 chr1 19072110 19075511 - H19 chr11 1995176 2001470 - KCNQ1OT1 chr11 2608328 2699994 - LINC01278 chrX 63222993 63561095 - MIR29B2CHG chr1 207801518 207879115 - NEAT1 chr11 65422774 65445540 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE140106 Sample Source: Blood Source Fraction: Exosome Platform: GPL11154 Method: NGS Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1907 Sample treatment protocol: Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). RNA Extract protocol: Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer's protocol. RNA library preparation protocol: Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer's instructions.

Reference

PMID: 31721043 Title: Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment Author: Ebrahimkhani S, Beadnall HN, Wang C, Suter CM, Barnett MH, Buckland ME, Vafaee F Journal: Mol Neurobiol. 2020 Feb;57(2):1245-1258. Description: we sought the possible utility of serum exosome microRNAs as biomarkers for disease activity in multiple sclerosis patients in response to fingolimod therapy.